Regenerative medicinal chemistry: The in situ control of stem cells

ACS Medicinal Chemistry Letters

Volumn 4, Issue 4, 2013, Pages 365-368

  Russell, Angela J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; ELTROMBOPAG; ERYTHROPOIETIN; FT 1050; GRANULOCYTE COLONY STIMULATING FACTOR; ISOXAZOLE DERIVATIVE; PLERIXAFOR; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT STEM CELL; ANEMIA; CELL ACTIVATION; CELL POPULATION; CELL REGENERATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MESENCHYMAL STROMA CELL; MULTIPLE MYELOMA; MULTIPOTENT STEM CELL; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SHORT SURVEY; STEM CELL NICHE; THROMBOCYTOPENIA; TISSUE DIFFERENTIATION; TISSUE REPAIR;

EID: 84876232139     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400110b     Document Type: Short Survey

References (10)

1. For a comprehensive summary of ongoing cell therapy clinical studies, see: Culme-Seymour, E. J.; Davie, N. L.; Brindley, D. A.; Edwards-Parton, S.; Mason, C. A decade of cell therapy clinical trials (2000-2010) Regener. Med. 2012, 7, 455-462
2. For an example of a recent review, see: Li, W.; Jiang, K.; Wei, W.; Shi, Y.; Ding, S. Chemical approaches to studying stem cell biology Cell Res. 2013, 23, 81-91
3. For an example of a recent review, see: Lyssiotis, C. A.; Lairson, L. L.; Boitano, A. E.; Wurdak, H.; Zhu, S.; Schultz, P. G. Chemical control of stem cell fate and developmental potential Angew. Chem., Int. Ed. 2011, 50, 200-242
4. Erickson-Miller, C. L.; DeLome, E.; Tian, S. S.; Hopson, C. B.; Stark, K.; Giampa, L.; Valoret, E. I.; Duffy, K. J.; Luengo, J. L.; Rosen, J.; Miller, S. G.; Dillon, S. B.; Lamb, P. Discovery and characterisation of a selective, nonpeptidyl thrombopoietin receptor agonist Exp. Hematol. 2005, 33, 85-93
5. Broxmeyer, H. E.; Orschell, C. M.; Clapp, D. W.; Hangoc, G.; Cooper, S.; Plett, P. A.; Liles, W. C.; Li, X.; Graham-Evans, B.; Campbell, T. B.; Calandra, G.; Bridger, G.; Dale, D. C.; Srour, E. F. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J. Exp. Med. 2005, 201, 1307-1318
6. North, T. E.; Goessling, W.; Walkley, C. R.; Lengerke, C.; Kopani, K. R.; Lord, A. M.; Weber, G. J.; Bowman, T. V.; Jang, I.-H.; Grosser, T.; Fitzgerald, G. A.; Daley, G. Q.; Orkin, S. H.; Zon, L. I. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis Nature 2007, 447, 1007-1011
7. For instance, see: Wilkinson, R. N.; Pouget, C.; Gering, M.; Russell, A. J.; Davies, S. G.; Kimelman, D.; Patient, R. Hedgehog and Bmp polarize hematopoietic stem cell emergence in the zebrafish dorsal aorta Dev. Cell 2009, 16, 909-916
8. Russell, J. L.; Goetsch, S. C.; Aguilar, H. R.; Frantz, D. E.; Schneider, J. W. Targeting native adult heart progenitors with cardiogenic small molecules ACS Chem. Biol. 2012, 7, 1067-1076
9. Russell, J. L.; Goetsch, S. C.; Aguilar, H. R.; Coe, H.; Luo, X.; Liu, N.; van Rooij, E.; Frantz, D. E.; Schneider, J. W. Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease ACS Chem. Biol. 2012, 7, 1077-1083
10. Smart, N.; Bollini, S.; Dubé, K. N.; Vieira, J. M.; Zhou, B.; Davidson, S.; Yellon, D.; Riegler, J.; Price, A. N.; Lythgoe, M. F.; Pu, W. T.; Riley, P. R. De novo cardiomyocytes from within the activated adult heart after injury Nature 2011, 474, 640-644